Joseph, N., Campbell, V., Pawlyn, C., Vogl, D., Holstein, S., Gooding, S., Creasey, T., Jenner, M., Chaidos, A., Rodriguez-Otero, P., Al-Kaisi, F., Brearton, G., Moore, S., O'Nions, J., Somervaille, T., Knurowski, T., Clegg, K., Frese, K., Paul, S., Searle, D. E. (2025). Randomized phase II dose optimization study of inobrodib (CCS1477), in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma (RRMM). Blood. https://doi.org/10.1182/blood-2025-4035